ఇంటర్నేషనల్ జర్నల్ ఆఫ్ అడ్వాన్స్ ఇన్నోవేషన్స్, థాట్స్ & ఐడియాస్

నైరూప్య

Allogenic Mesenchymal Stem cell Therapy for CADASIL patient first clinical Case Report

Vahideh Nasr

CADASIL, Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy, is an inherited small vessels disease that characterized by central nervous system dysfunctions caused by mutations in the Notch-3 gene. Clinical manifestations accrue due to brain’s vasculopathy, neurodegeneration, and immune system reaction. We describe here an effective method for treatment of CADASIL by using mesenchymal stem cell therapy. A CADASIL case, 36 years old man, neuroimaging and genetic analysis for Notch-3 confirmed the diagnosis, is reported. In the present case, two stem cell injections have been performed at intervals of three weeks. The patient had no significant complications in the post-transplant period. No immediate or delayed side effects following MSC infusion were observed